Managing IP Winter 2021 is now live

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2025

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Managing IP Winter 2021 is now live

Kathi Vidal, who has been nominated for the USPTO director role

Read about Kathi Vidal, AI legal decisions, trademark piracy in China, and much more in our digital-only quarterly

To access the issue, click here

A new era beckons at the USPTO as Kathi Vidal, managing partner of Winston & Strawn’s Silicon Valley office, looks set to become the office’s next director. She would be just the second woman to have held the role in more than 200 years.

However, we are being made to wait – Vidal may have been nominated by President Joe Biden, but she won’t be confirmed until the Senate says so. At the time of writing, that date is unconfirmed, and in the meantime the USPTO remains without a permanent leader despite the capable efforts of acting director Drew Hirshfeld, who is also patents commissioner.

With former director Andrei Iancu having departed in January 2021, it could be at least a year before we know whether Vidal will be the next director. That seems far too long.

Nonetheless, she would be a strong pick, at least according to the lawyers we have spoken to. Her leadership, managerial and litigation prowess will stand her in good stead for the role, our sources say, with one even describing her as a “powerhouse”.

That’s not to say, of course, that there won’t be challenging times ahead (assuming she is confirmed). Her biggest challenge will be managing the political turmoil surrounding discretionary denials at the Patent Trial and Appeal Board and the director review mandate set out by the Supreme Court in US v Arthrex. She may also have to manage the implementation of the Restoring the America Invents Act, should it be enacted by Congress.

You can read more about Vidal’s nomination and the road ahead in the cover story of this issue, which is our first digital-only quarterly. As you may be aware, we announced in October that we would no longer be printing magazines and would instead focus on fully digital products. There were a number of reasons for this change, not least the environmental concerns associated with printing and distributing publications globally.

Having said that, we are still able to offer this excellent issue in PDF form – and beyond the cover story mentioned above, you can find an array of expert analysis articles as well as the usual local insights updates from around the world. We hope you enjoy all of the content we have to offer.

Our next issue will be published in early 2022. The big question, though, is will we have a new USPTO director by then?

 

more from across site and SHARED ros bottom lb

More from across our site

Niri Shan, the newly appointed head of IP for UK, Ireland and the Middle East, explains why the firm’s international setup has brought UPC success, and addresses German partner departures
Vlad Stanese joins our ‘Five minutes with’ series to discuss potentially precedent-setting trademark and copyright cases and his love for aviation
Heath Hoglund, president of Via LA, discusses how it sets royalty rates and its plans to build on growth in China
Stobbs stands accused of interfering with the administration of justice after Brandsmiths’ client was subjected to an interim injunction for unjustified threats
The firm, known for its prosecution expertise, discusses its plans following the appointment of a UK-based patent litigation head and two new partners
Ed White at Clarivate provides an exclusive insight into the innovation power clusters reshaping Europe and the Middle East’s IP landscape, and why quality is the new currency of invention
In the first in a new podcast series celebrating the tenth anniversary of IP Inclusive, we look back at the network’s origins and discuss its mission
Rebecca Schwarz at Haynes Boone shares how her team secured victory for biopharma client RedHill in a licensing dispute involving a developmental cancer drug
News of a breakaway firm launching in Germany and a spike in vaccine-related patent applications were also among the top talking points
A flurry of hiring activity among UK firms suggests they are confident of mounting a serious challenge at the UPC
Gift this article